Arkolith/Insider Trading/GALT/Form 4

Lewis Joel

President and CEO, DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$321K
Net Open-Market Flow
-$321K
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 6, 2026Sell(S)38K$3.58$135K833K
Jan 5, 2026Sell(S)28K$3.91$108K870K
Jan 2, 2026Option exercise(M)84K—$0917K
Jan 2, 2026Sell(S)19K$4.20$78K898K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 2, 2026Option exercise(M)84K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for GALECTIN THERAPEUTICS INC

Build

Ask your agent about GALT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001133416-26-000008"
Ask your agent
Use Arkolith to summarize insider buying and selling at GALECTIN THERAPEUTICS INC
over the last 90 days and cite the filings.